Trading Signals: SGEN Stock Price Prediction and Forecast (Fri. May. 30, 2003 - Wed. Dec. 13, 2023)(Seattle Genetics, Inc.)
| SGEN latest price $118.0700 (0.1%) ($116.5900 - $119.2200) on Wed. Feb. 12, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.82% (three month average) | RSI | 54 | Latest Price | $118.0700(0.1%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | SGEN advances 2.4% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support SGEN advance at 0% a week (0% probability) XLC(34%) IYT(25%) VFMO(24%) BOTZ(23%) DIA(23%) | Factors Impacting SGEN price | SGEN will decline at least -0.91% in a week (0% probabilities). VIXM(-12%) VXX(-5%) UUP(-1%) TLT(-1%) SHY(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.91% (StdDev 1.82%) | Hourly BBV | 0 () | Intraday Trend | -0.1% | | | |
|
5 Day Moving Average | $117.72(0.3%) | 10 Day Moving Average | $114.75(2.89%) | 20 Day Moving Average | $112.84(4.63%) | To recent high | -2.9% | To recent low | 11.9% | Market Cap | $20.528b | | | | Seattle Genetics, Inc. is a biotechnology company, which engages in the development and commercialization of antibody-based therapies for the treatment of cancer. Its products include Adcetris and Padcev. The firm is also advancing a pipeline of novel therapies for solid tumors and blood-related cancers. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA. |